Search Results

In The Media STAT

Reformulating Drugs Helps Profits More Than Patients

Author

Featured Fellow:

• Ravi Gupta, MD

June 17, 2022

In The Media Bloomberg Law

A COVID-19 Vaccine IP Waiver Won’t Kill Pharma Innovation

Author

Featured Fellow:

• Ravi Gupta, MD

September 24, 2021

Blog Post

COVID-19 | Population Health

During COVID-19, FDA’s Vaccine Advisory Committee Has Worked To Boost Public Trust – It Can Still Do More

By:

• Ravi Gupta, MD, Genevieve Kanter, PhD

March 3, 2021

In The Media FAIR

The Ones With the Most Risk Are the Ones We’re Most Ill-Prepared to Reach with the Vaccine

Interview

Featured Fellow:

• Ravi Gupta, MD

December 7, 2020

In The Media KNX 1070 Newsradio

Trump Foot Dragging On COVID Management Transition to Biden Called Out – Sweden Is a Cautionary Tale Again – a Window Into Our Pandemic Lives, via Our Trash Cans

Interview

Featured Fellow:

• Ravi Gupta, MD

November 18, 2020

In The Media New York Times

Does Remdesivir Actually Work Against Covid-19?

Author

Featured Fellow:

• Ravi Gupta, MD

November 17, 2020

In The Media Boston Review

Our Vaccine Infrastructure Needs a Radical Overhaul

Author

Featured Fellow:

• Ravi Gupta, MD

November 16, 2020

In The Media Journal of General Internal Medicine

Medicare Formulary Coverage Of Brand-Name Drugs And Therapeutically Interchangeable Generics

Author

Featured Fellow:

• Ravi Gupta, MD

July 21, 2020